Gadgets, Business and Technology

Although chemotherapy and surgery are the most common forms of treatment, participating in clinical trials can provide you with alternative mesothelioma treatment options. Increased awareness of mesothelioma and other asbestos-caused diseases has led to an increase on medical research to cure and control asbestos-caused cancers and related asbestos heart and respiratory diseases. Mesothelioma treatment and treatment options for advanced malignant mesothelioma are not limited to surgery and chemotherapy.

Advanced malignant mesothelioma clinical studies with Cisplatin, now often used with chemotherapy, proved Cisplatin to be effective. Drugs produce a medical benefit by themselves, and they can produce a different benefit when combined with other drugs – a chemical reaction that produces a third result. Mesothelioma clinical trials with Gemcitabine proved Gemcitabine to be ineffective. Perhaps the most common clinical trials and mesothelioma treatment options for advanced malignant mesothelioma involve chemotherapy and drug combinations. However, mesothelioma clinical trials using Cisplatin and Gemcitabine together are proving to be even more promising. Finding the right drug combinations to slow tumor growth and contribute to improved pain management is one of the fastest paths to wide-spread availability of new mesothelioma treatment options.

Anti-angiogenic therapies focus on natural body substances that affect the mesothelioma cancer’s growth, including the use of drugs made of these substances to inhibit cancer growth factors. Advanced malignant mesothelioma patients have a higher vascular endothelial growth factor than patients with other cancers.Anti-angiogenic therapy are a biological therapy based on interfering with the blood vessels that the cancer needs to survive.

Immunotherapy is also classified as a biological therapy. It concentrates on building immunity to the cancer cells. Immunotherapy can involve vaccines, and in cases of mesothelioma, these are likely to be injected in the pleural region. IL-2 is made naturally by the body, and clinical trials have demonstrated its success at treating mesotheliomas in the early stages, mesothelioma stages one and two, but not effective in treating advanced malignant mesothelioma.

Photodynamic therapy has gained increase attention in many medical fields for various treatment options, including mesothelioma treatment. Photodynamic therapy uses light and heat to kill cancer cells. It has been successful in treating other cancers.

Gene therapy is also a biological therapy and explores using the body’s natural substances to treat mesothelioma stages. The medical premise is to replace the genes in cancer cells with healthy genes. Oncogenes contribute to the fast spreading of the cancer cells and tumor suppressor genes stop cells from spreading.

Mesothelioma treatment for advanced malignant mesothelioma is slowly finding new mesothelioma treatment options. It takes years to evaluate the clinical significance of a clinical trial and medical research to prove that a mesothelioma treatment option is a promising and viable alternative. Thorough medical research on mesothelioma treatment contributes to safe medical treatment options being widely-available to the public. Mesothelioma in any of its stages is dangerous, but with researchers working together, mesothelioma treatment options will be safer and mesothelioma research will someday find a cure.

Advanced malignant mesothelioma can be treated by following one or more of the options mentioned above as it is necessary.

Mesothelioma treatment and treatment options for advanced malignant mesothelioma are not limited to surgery and chemotherapy. Increased awareness of mesothelioma and other asbestos-caused diseases has led to an increase on medical research to cure and control asbestos-caused cancers and related asbestos heart and respiratory diseases. Although chemotherapy and surgery are the most common forms of treatment, participating in clinical trials can provide you with alternative mesothelioma treatment options.

Perhaps the most common clinical trials and mesothelioma treatment options for advanced malignant mesothelioma involve chemotherapy and drug combinations. Drugs produce a medical benefit by themselves, and they can produce a different benefit when combined with other drugs – a chemical reaction that produces a third result. Advanced malignant mesothelioma clinical studies with Cisplatin, now often used with chemotherapy, proved Cisplatin to be effective. Mesothelioma clinical trials with Gemcitabine proved Gemcitabine to be ineffective. However, mesothelioma clinical trials using Cisplatin and Gemcitabine together are proving to be even more promising. Finding the right drug combinations to slow tumor growth and contribute to improved pain management is one of the fastest paths to wide-spread availability of new mesothelioma treatment options.

Anti-angiogenic therapy is a biological therapy based on interfering with the blood vessels that the cancer needs to survive. Advanced malignant mesothelioma patients have a higher vascular endothelial growth factor than patients with other cancers. Anti-angiogenic therapies focus on natural body substances that affect the mesothelioma cancer’s growth, including the use of drugs made of these substances to inhibit cancer growth factors.

Immunotherapy is also classified as a biological therapy. Immunotherapy, as the name suggests, concentrates on building immunity to the cancer cells. Immunotherapy can involve vaccines, and in cases of mesothelioma, these are likely to be injected in the pleural region. IL-2 is made naturally by the body, and clinical trials have demonstrated its success at treating mesotheliomas in the early stages, mesothelioma stages one and two, but not effective in treating advanced malignant mesothelioma.

Photodynamic therapy has gained increase attention in many medical fields for various treatment options, including mesothelioma treatment. Photodynamic therapy uses light and heat to kill cancer cells. Unfortunately, clinical trials have not been successful with advanced mesothelioma patients, nor patients in the mesothelioma patients in stages one and two. It has been successful in treating other cancers.

Gene therapy, also referred to as molecular therapy, is an exciting and relatively new field of research being applied to mesothelioma treatment. Oncogenes contribute to the fast spreading of the cancer cells and tumor suppressor genes stop cells from spreading. The medical premise is to replace the genes in cancer cells with healthy genes. Gene therapy is also a biological therapy and explores using the body’s natural substances to treat mesothelioma stages.

Mesothelioma treatment for advanced malignant mesothelioma is slowly finding new mesothelioma treatment options. It takes years to evaluate the clinical significance of a clinical trial and medical research to prove that a mesothelioma treatment option is a promising and viable alternative. Thorough medical research on mesothelioma treatment contributes to safe medical treatment options being widely-available to the public. Mesothelioma in any of its stages is dangerous, but with researchers working together, mesothelioma treatment options will be safer and mesothelioma research will someday find a cure.

Peritoneal mesothelioma is less common than pleural mesothelioma, but both of these typically malignant mesotheliomas can be just as tragic. Peritoneal mesothelioma begins in the abdominal cavity, as opposed to the lungs and pleural areas of pleural mesothelioma. “Peritoneal” means it has to do with the peritoneum, which is a membrane that surrounds the abdominal area. “Pleural” refers to the pleura which is a membrane that surrounds the lungs. There is also a “pericardial” mesothelioma which targets the heart membrane first.

The lungs, abdominal area and heart all have a membrane made up of mesothelial cells, named the mesothelium. A cancerous attack of these membrane areas are mesotheliomas. Asbestos is the cause of peritoneal mesothelioma, pleural mesothelioma and pericardial mesothelioma in well over 90% of the cases. There are a few rare recorded cases of malignant mesothelioma when asbestos exposure was not identified. If you have been exposed to asbestos, there is a high chance you will suffer from an asbestos-caused disease such as asbestosis or pleural plaques. However, not all asbestos-caused diseases are fatal.

Peritoneal mesothelioma, pleural mesothelioma and pericardial mesothelioma can be fatal malignant mesotheliomas which spread uncontrollably, or they can be benign, when the tumor stays where it is and can likely be removed. Unexplainable weight loss is a mesothelioma symptom which may occur in as many as 90% of benign and malignant mesothelioma. Generally, benign mesothelioma tends to show less symptoms than malignant mesothelioma. Mesothelioma symptoms for peritoneal mesothelioma almost always includes abdominal pain. This is because there is excess fluid between the peritoneal membrane and the abdomen walls. Pleural mesothelioma has excess fluid in the pleural area and this causes shortness of breath and chest pain.

The mesothelioma symptoms of pleural mesothelioma and pericardial mesothelioma are not as outwardly visible as the symptoms of peritoneal mesothelioma. In peritoneal mesothelioma, the abdomen can appear larger. Tumor masses may be visible, but external tumor visibility only occurs in a minority of peritoneal mesothelioma cases. Nausea is a common mesothelioma symptom with peritoneal mesothelioma, and the abdominal area will also be very tender.

In a healthy peritoneal area between the membrane and the wall, the peritoneal fluid helps the intestines move food. In peritoneal mesothelioma however, excess fluid causes bowel obstruction. The mesothelioma symptoms of extra fluid and bowel obstruction both contribute to abdominal pain. The bowel obstruction can also produce mesothelioma symptoms of constipation and diarrhea. Many peritoneal malignant mesothelioma patients have reported mesothelioma symptoms of a burning sensation in the abdomen. Mesothelioma symptoms for peritoneal malignant mesothelioma may not surface for 20-30 years after asbestos exposure, but it generally surfaces sooner than pleural mesothelioma.

Peritoneal mesothelioma is fortunately rare, however its rarity sometimes makes it harder to diagnose. The symptoms are similar to hernias and gall bladder problems, and identifying peritoneal mesothelioma in a CT scan is difficult. The medical industry is aware that asbestos-related diseases will be escalating over the upcoming years, and treatment for peritoneal malignant mesothelioma is undergoing many clinical trials. If you have been exposed to asbestos and have unexplainable abdominal pain and are experiencing unexplained weight loss, begin preliminary testing for peritoneal mesothelioma. The sooner the testing begins, the higher the chances for symptomatic relief, and hopefully today’s mesothelioma clinical trials will lead to a mesothelioma cure in the future.

Mesothelioma treatment options for malignant mesothelioma can relieve pain and provide hope for the future. In many cases, new mesothelioma treatment options can increase mesothelioma life expectancy beyond original expectations. Even if advanced malignant mesothelioma has reached a seemingly incurable stage, participating in clinical trials gives a breath of hope to the future generations of mesothelioma cancer patients.

Treatment for malignant mesothelioma can start with surgery, although this is not always recommended in mesothelioma treatment options since older patients may have a difficult time with surgery. The objective is to remove the tumor, or at least most of it, and slow down the disease. With advanced mesothelioma, the tumor has often tragically spread throughout the body and has invaded life-giving organs, making surgery more risky than living with cancer itself. However in the early stages of malignant mesothelioma, a localized tumor is more likely to be successfully removed.

Radical surgery is a mesothelioma treatment option for advanced malignant mesothelioma that has been used in small clinical trials, but has resulted in almost half the patients (48%) living at least five years past their predetermined mesothelioma life expectancy date. “Extrapleural pneumonectomy” involves removing the internal body parts that mesothelioma cancer cells love to invade. Surgery removes the parietal pleura (pleural mesothelioma), the pericardium (pericardial mesothelioma) and the diaphragm, as well as the removal of a lung. This surgery is combined with pre and post operative chemotherapy and radiotherapy. Cancer Research UK is funding a “MARS” clinical trial (mesothelioma and radical surgery) to formally undergo pilot testing. Since the patients must be followed for five years, the results are not yet available and the success of these mesothelioma treatment options has yet to be discovered. UK medical reports do claim that US trial results have thus far demonstrated that a heavier dose of radiotherapy after the EPP surgery extends mesothelioma life expectancy.

Mesothelioma treatment options almost always include chemotherapy. Progress is seen in mesothelioma treatment when chemotherapy is combined with drug therapy. There are clinical trials for mesothelioma treatment options around the world that are seeking to find the chemotherapy and drug mix that can prolong mesothelioma life expectancy. Clinical trials are listed at many cancer organizations and research hospitals, and many seek mesothelioma patients wanting mesothelioma treatment options for advanced malignant mesothelioma. In advanced malignant mesothelioma, participating in a clinical trial can be a lifesaving mesothelioma treatment option.

Mesothelioma treatment options for advanced malignant mesothelioma can also be found in clinical trials for anti-angiogenic therapy. Anti-angiogenic mesothelioma treatment options are biological therapies that revolve around blood vessel growth. A cancer needs its own blood supply to grow. Two primary chemicals contribute to growth, VEGF and FGF-2. Mesothelioma patients with advanced malignant mesothelioma have higher levels of VEGF compared to patients suffering from other cancers. The theory the clinical trials are hoping to prove is that blocking VEFG will stop the blood vessel growth that supports the cancer growth.

Mesothelioma treatment options for malignant mesothelioma also includes clinical trials in phototherapy, immunotherapy, gene therapy and other therapies. Medical specialists are scrambling to find the mesothelioma treatment options for malignant mesothelioma that can protect and cure the projected increase in mesothelioma patients of the future. Participating in clinical trials can extend mesothelioma life expectancy and provide hope for future generations.